Pharming

Pharming Group is a developer and producer of human therapeutic proteins and more medical products in Netherlands. Read more

2,101 Followers on Owler
2,101 Followers on Owler
2,101 Followers on Owler
2,101 Followers on Owler

Pharming

Pharming Group is a developer and producer of human therapeutic proteins and more medical products in Netherlands. Read more

Sijmen De Vries's photo - Chairman & CEO of Pharming

Chairman & CEO

Sijmen De Vries

CEO Approval Rating

72/100

Founded:

1988

Status:

PublicIndependent CompanyOtherPHARM

Annual Revenue
Employees
Headquarters
Leiden

PHARMING TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

BioCryst is perceived as one of Pharming's biggest rivals. BioCryst was founded in 1986 in Durham, North Carolina. BioCryst is in the Pharmaceuticals field. BioCryst generates $196M less revenue than Pharming.

KalVista is Pharming's #2 rival. KalVista is a Public company that was founded in 2004 in Cambridge, Massachusetts. KalVista competes in the Biotechnology field. Compared to Pharming, KalVista has 173 fewer employees.

CSL Behring is one of Pharming's top competitors. CSL Behring's headquarters is in King of Prussia, Pennsylvania, and was founded in 1904. CSL Behring operates in the Pharmaceuticals industry. CSL Behring generates 3,989% of Pharming's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Shire a competitor of Pharming?

Pharming Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$228.1M

Pharming's revenue is the ranked 24th among it's top 10 competitors. The top 10 competitors average 14.1B. Over the last three quarters, Pharming's revenue has grown by 205.5%. Specifically, in Q4 2020's revenue was $131.2M; in Q3 2020, it was $54M; in Q2 2020, it was $42.9M.

Pharming Acquisitions

No recent acquisitions found related to Pharming

Pharming Funding History

Since Pharming was founded in 1988, it has participated in 2 rounds of funding. In total Pharming has raised $117.0M. Pharming's last funding round was on May 2017 for a total of $100.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
May 2017
$100M

OrbiMed Advisors

Debt
Jul 2015
$17M

Since Pharming was founded in 1988, it has participated in 2 rounds of funding. In total Pharming has raised $117.0M. Pharming's last funding round was on May 2017 for a total of $100.0M

Pharming Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

BioConnection focuses on development and production of injectable biopharmaceutical products.
$1.6M
Mar 28, 2019
Equity
-

Pharming News

April 7, 2021FinanzNachrichten

Pharming Group announces the filing of its 2020 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission

LEIDEN, Netherlands, April 7, 2021 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") ... See more »
March 23, 2021Markets Insider

Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors

LEIDEN, Netherlands, March 23, 2021 /PRNewswire/ -- Pharming Group N.V. ('Pharming' or 'the Company')... See more »
March 16, 2021FinanzNachrichten

Pharming Group to present at 31st Annual Oppenheimer Healthcare Conference

LEIDEN, Netherlands, March 16, 2021 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company")... See more »
March 11, 2021Markets Insider

Pharming Group to Present at BioCapital Europe 2021

LEIDEN, The Netherlands, March 11, 2021 /PRNewswire/ -- Pharming Group N.V. ('Pharming' or 'the Compa... See more »
March 4, 2021Markets Insider

Pharming Group reports financial results for full year 2020

LEIDEN, Netherlands, March 4, 2021 /PRNewswire/ -- Pharming Group N.V. ('Pharming' or 'the Company') ... See more »
March 2, 2021MarketScreener

Group, in collaboration with Invitae Corporation, launches genetic testing program 'navigateAPDS' in US and Canada

(marketscreener.com) Pharming Group, in collaboration with Invitae Corporation, launches genetic test... See more »
December 22, 2020FinanzNachrichten

Pharming Group announces ADSs admitted to trade on Nasdaq under the symbol "PHAR"

U.S. SEC declares registration statements effective Each ADS represents 10 ordinary shares The Compan... See more »

Pharming Press Releases

June 16, 2016Business Wire

Global Alpha-Galactosidase A (Alpha-D-Galactosidase A or Alpha-D-Galactoside Galactohydrolase or Melibiase or EC 3.2.1.22) Therapeutics Pipeline Review 2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Alpha-Galactosidase ... See more »
May 24, 2016PR Newswire

Pharming Reports on Annual General Meeting of Shareholders Pharming's Board of Supervisory Directors Announce Paul Sekhri as New Chairman

LEIDEN, The Netherlands, May 25, 2016 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company... See more »
April 29, 2016PR-Inside

Pharming Group N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

(PR-inside.com) Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Inves... See more »
December 7, 2015PR Newswire

European Medicines Agency Reaffirms Important Health Benefits and Safety of RUCONEST® for Patients With Hereditary Angio-edema

LEIDEN, The Netherlands, December 7, 2015 /PRNewswire/ -- Pharming Launches RUCOVITAE On-Demand Care ... See more »
October 28, 2015PR NEWSWIRE

Pharming Reports on Extraordinary General Meeting of Shareholders

LEIDEN, The Netherlands, October 28, 2015 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Com... See more »
October 28, 2015PR NEWSWIRE

Pharming Group NV Interim Report January - September 2015

LEIDEN, The Netherlands, October 28, 2015 /PRNewswire/ -- Biotech company Pharming Group N.V. ("Pharm... See more »
October 8, 2015PR NEWSWIRE

FDA Grants RUCONEST® (C1 Esterase Inhibitor [Recombinant]) Twelve-Year Reference Product Exclusivity

LEIDEN, Netherlands and BRIDGEWATER, New Jersey, October 8, 2015 /PRNewswire/ -- Pharming Group NV (E... See more »

Pharming Videos

Social Media

Pharming Headquarters

Darwinweg 24

Leiden, Other2333

0-71-5247-400

Driving Directions »

Trending Companies

Pharming Summary

ABOUT

Overview

Pharming Group is a developer and producer of human therapeutic proteins and more medical products in Netherlands. Pharming was founded in 1988. Pharming's headquarters is located in Leiden, Other, NL 2333. It has raised 117.0M in 2 rounds. The latest...

CEO

Pharming's Chairman & CEO, Sijmen De Vries, currently has an approval rating of 72%. Pharming's primary competitors are BioCryst, KalVista & CSL Behring.

Website

pharming.com

Frequently Asked Questions about Pharming

  1. When was Pharming founded?

    Pharming was founded in 1988
  2. Who is Pharming's CEO?

    Pharming's CEO is Sijmen De Vries
  3. How much revenue does Pharming generate?

    Pharming generates $228.1M in revenue
  4. How much funding does Pharming have?

    Pharming has historically raised $117M in funding
  5. Where is Pharming's headquarters?

    Pharming's headquarters is in Leiden Other, NL
  1. How many employees does Pharming have?

    Pharming has 229 employees
  2. What sector does Pharming operate in?

    Pharming is in Biotechnology
  3. Who are Pharming's competitors?

    Pharming's top competitors are BioCryst, KalVista, CSL Behring
  4. Who has Pharming invested in?

    Pharming's has invested in companies such as BioConnection